Search

Your search keyword '"Field, T"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Field, T" Remove constraint Author: "Field, T" Publisher elsevier bv Remove constraint Publisher: elsevier bv
48 results on '"Field, T"'

Search Results

4. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

7. Touch Research Institutes: an interview with Dr Tiffany Field

8. Meniscal repair in very young children

9. Septic Arthritis Following Arthroscopic Meniscus Repair: A Cluster of Three Cases

10. Effect of humeral head component size on hemiarthroplasty translations and rotations

11. Dissociation of modular humeral head components: A biomechanical and implant retrieval study

12. BIOLOGY OF THE ROTATOR CUFF TENDON

14. Effectiveness of Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: Results of a Donor Vs. No Donor Analysis

15. Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

16. Prospective Trial of Pre-Transplant 5-Azacitidine on Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndrome and CMML

20. ATG for the Prevention of Severe Acute Graft-Versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation

21. Patient Ethnicity Markedly Affects The Probability Of Finding An HLA-A, -B, -C, And DRB1 Allele Matched Unrelated Donor For Hemopoietic Cell Transplantation

22. A Novel Reduced Toxicity Preparative Regimen For Hematopoietic Cell Allografting Combining Pentostatin (Nipent®) And Targeted Doses Of Intravenous Busulfan (Busulfex®) With Or Without Rituximab (PB±R) Using CD4-Guided Immune Suppression: Preliminary Results Of An Ongoing Prospective Trial

24. Primary Plerixafor Mobilization In Autologous Hematopoietic Cell Transplant Candidates At High Risk For Mobilization Failure

27. A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival

29. Long–Term Survival of Allogeneic Transplantation(Allo SCT) In Selected Patients with Multiple Myeloma (MM): Disease Free Survival at Two Years May Indicate Long Term Survival

30. Safety Profile of Pharmacokinetically Targeted Intravenous Busulfan Combined with Fludarabine (BuFlu) as Conditioning Prior to Allogeneic Peripheral Blood Hematopoietic Cell Transplant

31. Autologous Stem Cell Transplantation (ASCT) In Patients Aged ≥65 Years With Multiple Myeloma: Moffitt Cancer Center Experience

32. PROSTATE CANCER SPECIFIC SURVIVAL OF A COHORT OF OVER 20,000 MEN TREATED EITHER CONSERVATIVELY OR WITH DEFINITIVE TREATMENT (RADIOTHERAPY OR RADICAL PROSTATECTOMY)

33. 330: Rituximab is Feasible to Administer to Allograft Recipients with Advanced CD20+ Malignancies and does not Affect Timely Hematopoietic Engraftment

34. 156: Treatment of Myeloid Malignancies in Elderly Patients with Fludarabine and Targeted Busulfan (t-Bu) and Allogeneic Hematopoietic Cell Transplantation (HCT)

35. 184: Phase I Study of Bortezomib, (BTZ) followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL)

39. Meniscal repair in very young children

40. A phase i study of high-dose melphalan + topotecan + VP-16 phosphate (Mtv) Followed by autologous stem cell rescue in multiple myeloma

48. Dissociation of modular shoulder arthroplasty components

Catalog

Books, media, physical & digital resources